Equashield

Closed-system Transfer Devices for Safe Handling of Hazardous Drugs

Health Tech & Life Sciences
Acquired by Nordic Capital
Acquired תפן Founded 2009
Total raised
Last: Secondary 2024-08
Stage
Acquired
Founded
2009
Headcount
126
HQ
תפן
Sector
Health Tech & Life Sciences

About

Equashield Medical provides advanced, automated solutions to protect healthcare workers and facilities from the risks associated with hazardous drug exposure and contamination. The company has developed two major patented products: Equashield CSTD and Equashield Pro. Equashield CSTD is an airtight closed-system drug-transfer device that protects against occupational exposure to hazardous drugs. Equashield Pro is an automatic compounding system specially designed to handle multiple tasks simultaneously while using advanced proprietary image-processing algorithms to monitor and control all stages of the process.

Funding history · 1 round · — total

2024-08
Secondary Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Machinery & RoboticsProcessing MachineryIndustrial Robots
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 Patents

Tags

automationdrugs-managementmedical-devices